Analyst Ratings for Panbella Therapeutics (PBLA)

PBLA Rating Summary

PBLA Price Target Summary

* Over Last 12-Mos
  |   Expand Research on PBLA
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $9.00 (+291.3%) * Over Last 12-Mos
Rating Score: 10 / 10
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/28/2021 Roth Capital Tony Butler New Coverage Buy
(N/A)
10.00
(N/A)
3.55
(2.30)
-35.21% Details
3/10/2021 Maxim Group Jason McCarthy New Coverage Buy
(N/A)
8.00
(N/A)
4.17
(2.30)
-44.84% Details
Like PBLA Ratings? Also take a look at CYTR, ORPH, CERC, DCTH

PBLA Ratings News